Daphne Williams

1.0k citations

30 papers · 830 indexed · h-index 14

Impact in

Hematology top 2%
- Platelet Disorders and Treatments
- Blood groups and transfusion
Cell Biology top 10%
- Microtubule and mitosis dynamics

Papers in

Hematology 10
- Platelet Disorders and Treatments 8
- Blood groups and transfusion 5
Oncology 12
- Cancer Treatment and Pharmacology 3
- Cancer-related Molecular Pathways 3

Co-authors: J.M. Jenkins Yanli Deng David Collins Connie L. Erickson‐Miller Bin Peng V. S. Kitchen Mary Beth Wire Jung Wook Park
Journals: Journal of Clinical Oncology (9 papers)Annals of Oncology (2 papers)The Journal of Clinical Pharmacology (2 papers)British Journal of Clinical Pharmacology (2 papers)Blood (2 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Daphne Williams

29 papers receiving 807 citations

Peers

Countries citing papers authored by Daphne Williams

Since Specialization

Citations

This map shows the geographic impact of Daphne Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daphne Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daphne Williams more than expected).

Fields of papers citing papers by Daphne Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daphne Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daphne Williams. The network helps show where Daphne Williams may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daphne Williams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daphne Williams Line = papers co-authored together Daphne Williams links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Association Between Abatacept Exposure Levels and Infection Occurrence in Patients With Rheumatoid Arthritis: Post Hoc Analysis of the AVERT-2 Study The Journal of Rheumatology ·Paul Emery, R. Fleischmann, Robert Wong, 祖荣祥, Yoshiya Tanaka, Vivian P. Bykerk, Elaine Anita Ige, T. Huizinga, Gustavo Citera, Vidya Perera, Bindu Murthy, Shaelynn Garner, Julie Passarell, William D. Hedrich, Daphne Williams	2025	0
2	Phorbol esters isolated from Croton megalobotrys reverse HIV latency ex vivo Journal of Virus Eradication ·Ian Tietjen, Carla Espinoza-Vallejos, Daphne Williams, Rino Romadhoni, Yanhui Cai, Amélie Pagliuzza, Nicolas Chomont, Raymond J. Andersen, Luis J. Montaner, Kerstin Andrae‐Marobela	2019	1
3	Initial results from a phase I/IIa trial evaluating BMS-986158, an inhibitor of the bromodomain and extra-terminal (BET) proteins, in patients (pts) with advanced cancer Annals of Oncology ·John Hilton, Mihaela Cristea, Mark Voskoboynik, Sophie Postel‐Vinay, William J. Edenfield, Ashvinikumar V. Gavai, Susan Wee, Ljungberg Joel, Anke Klippel, Alkis, Sen Osman, Scott D. Chasalow, Daphne Williams, Mark Donovan, J. P. Foerst, Sophia K. Khaldoyanidi, Jennifer R. Diamond	2018	15
4	A phase 1/2 trial of a monoclonal antibody targeting fucosyl GM1 in relapsed/refractory small cell lung cancer (SCLC): Safety and preliminary efficacy Annals of Oncology ·Quincy S. Chu, Ben Markman, Natasha B. Leighl, Lee M. Krug, Charles M. Rudin, Deanne Lathers, Paul Basciano, Paula M. Fracasso, Georgia Kollia, Penny Phillips, Gerry Kolaitis, Daphne Williams, Jeffrey R. Jackson, Neal Ready	2016	3
5	Population PK/PD modeling of eltrombopag in subjects with advanced solid tumors with chemotherapy-induced thrombocytopenia Cancer Chemotherapy and Pharmacology ·R Apéry, Paul N. Mudd, Danièle Ouellet, Brendan M. Johnson, Daphne Williams, Ekaterina Gibiansky	2013	16
6	Metabolism and Disposition of Eltrombopag, an Oral, Nonpeptide Thrombopoietin Receptor Agonist, in Healthy Human Subjects Drug Metabolism and Disposition ·Yanli Deng, Bettina Treske, Mary Beth Wire, Carolyn J. Bowen, Jung Wook Park, Daphne Williams, Bin Peng, Ernest M. Schubert, Géraldine Huyghe, Mark A. Levy, Peter D. Gorycki	2011	38
7	Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers British Journal of Clinical Pharmacology ·Alicia J. Allred, Carolyn J. Bowen, Jung Wook Park, Bin Peng, Daphne Williams, Mary Beth Wire, Akande Eo	2011	63
8	Pharmacokinetics and Pharmacodynamics Clinical Pharmacokinetics, Platelet Response, and Safety of Eltrombopag at Supratherapeutic Doses of up to 200 mg Once Daily in Healthy Volunteers The Journal of Clinical Pharmacology ·AmiraFahmy Ali, Jung Wook Park, SENA E.F., Mary Beth Wire, Carolyn J. Bowen, Daphne Williams, J.M. Jenkins, Bin Peng	2010	22
9	Eltrombopag does not affect cardiac repolarization: results from a definitive QT_c study in healthy subjects British Journal of Clinical Pharmacology ·AmiraFahmy Ali, Jung Wook Park, SENA E.F., Mary Beth Wire, Jianping Zhang, Carolyn J. Bowen, Daphne Williams, J.M. Jenkins, Bin Peng	2010	18
10	A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors Investigational New Drugs ·Howard A. Burris, Suzanne F. Jones, Daphne Williams, Steven J. Kathman, Jeffrey P. Hodge, Lini Pandite, Peter Ho, Scott A. Boerner, Patricia LoRusso	2010	52
11	Effect of Hepatic or Renal Impairment on Eltrombopag Pharmacokinetics The Journal of Clinical Pharmacology ·John W. Bauman, D Dowiacka-Okruszko, Bin Peng, Mary Beth Wire, Daphne Williams, Jung Wook Park	2010	30
12	Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: Two single-dose, open-label, randomized-sequence, crossover studies Clinical Therapeutics ·Daphne Williams, Bin Peng, Christine K. Bailey, Mary Beth Wire, Yanli Deng, Jung Wook Park, David Collins, De Gui Liu, J.M. Jenkins	2009	76
13	A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours British Journal of Cancer ·Sarah P. Blagden, L. Rhoda Molife, M. Vališ M, Miranda Payne, Alison Reid, Andrew Protheroe, Lakshmi Vasist, Daphne Williams, Chester L. Bowen, Steven J. Kathman, Jeffrey P. Hodge, Mohammed M. Dar, Johann S. de Bono, Mark R. Middleton	2008	63
14	Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist Blood ·J.M. Jenkins, Daphne Williams, Yanli Deng, Nguyen Anh Quoc, V. S. Kitchen, David Collins, Connie L. Erickson‐Miller	2007	224
15	640 POSTER Phase I study of ispinesib (SB-715992), a kinesin spindle protein inhibitor, in combination with capecitabine in patients with advanced solid tumors European Journal of Cancer Supplements ·Jordi Rodón, Neda Khafri, Jonna Hurme, Chris H. Takimoto, M. Beeram, Daphne Williams, Carolyn J. Bowen, Jeffrey P. Hodge, Magano Mutepua, Saida Yasunobu	2006	10
16	Phase I trial of novel kinesin spindle protein (KSP) inhibitor SB-715992 IV days 1, 8, 15 q 28 days Journal of Clinical Oncology ·Howard A. Burris, Patricia LoRusso, Suzanne F. Jones, Tina Guthrie, 周光义, Daphne Williams, Jeffrey P. Hodge, Mark Bush, James H. Sabry	2004	25
17	rhBMP‐Collagen Sponges as Osteoinductive Devices: Effects of in Vitro Sponge Characteristics and Protein pI on in Vivo rhBMP Pharmacokinetics Annals of the New York Academy of Sciences ·Hasan Uludağ, Wolfgang Frieß, Daphne Williams, Thomas J. Porter, Strungaru Scedil tefan-Adrian, Darren DʼAugusta, C. A. Blake, W. S. Yang, Majd N. Bohssas, John M. Wozney	1999	66
18	Immunologic Markers in a Longitudinal Study of Aging in Pigtailed Macaques (Macaca nemestrina) Journal of Gerontology ·Douglas M. Bowden, Robert Short, Daphne Williams, Edward A. Clark	1994	6
19	Genetic Associations of Transitional Cell Carcinoma British Journal of Urology ·B. E. Kim, Reed A. Cartwright, Daphne Williams	1979	12
20	Radiommunoassay of delta9-tetrahydrocannabinol. PubMed ·Charles E. Cook, 阿丑, Amnuay Sae-Tang, Raquel Martı́n-Jadraque, Daphne Williams	1976	1

About Daphne Williams

Daphne Williams is a scholar working on Hematology, Oncology, Cell Biology, Cancer Research and Immunology, having authored 30 papers that have together received 830 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (8 papers), Microtubule and mitosis dynamics (7 papers), Blood groups and transfusion (5 papers), Cancer Genomics and Diagnostics (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Cancer Treatment and Pharmacology (3 papers), Diabetes Treatment and Management (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Hematology (399 citations), Cell Biology (175 citations), Genetics (87 citations), Oncology (211 citations) and Hepatology (36 citations). Daphne Williams has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include J.M. Jenkins, Yanli Deng, David Collins, Connie L. Erickson‐Miller, Bin Peng, V. S. Kitchen, Mary Beth Wire, Jung Wook Park, Jeffrey P. Hodge and Carolyn J. Bowen. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact